About us
News & Articles
Branding and Advertising
Consumer Behavior and CRM
Entertainment
Expert Views
Financial Markets & Services
Latest from Marketing World
Market Data
Marketing Ethics
Marketing Guru Speaks
Marketing Research
Product Reviews
Sales and Distribution
Social Media Marketing
social media marketing
sports
Market Intelligence & Research
Skilling Programs
Case studies
Contact Us
Contribute Articles
Search
About us
News & Articles
All
Branding and Advertising
Marketing Research
Social Media Marketing
social media marketing
Consumer Behavior and CRM
Marketing Ethics
A Season of High Drama and High Ratings: Bigg Boss Marathi Bows Out in Style
October 5, 2024
TANISHQ PRESENTS ‘NAV-RAANI’ COLLECTION; ROYAL JEWELLERY FOR MODERN DAY QUEENS
October 5, 2024
Godrej Properties delivers its highest ever Q2 and H1 bookings, collections, operating cash flow, and new business development
October 5, 2024
REFCOLD India 2024 Opens in Kolkata, Leading the Way in Advanced Cold Chain Solutions Amid Growing Market Demand
October 5, 2024
Market Intelligence & Research
Skilling Programs
Case studies
Contact Us
Contribute Articles
Home
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharmaceuticals
Alembic Pharmaceuticals announces USFDA Final Approval for Alcaftadine Ophthalmic Solution, 0.25% (OTC)
Passionate in Marketing
-
October 5, 2024
0
